BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yildirim Z, Sahin OS, Yazar S, Bozok Cetintas V. Genetic and epigenetic factors associated with increased severity of Covid-19. Cell Biol Int 2021;45:1158-74. [PMID: 33590936 DOI: 10.1002/cbin.11572] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Ali HN, Niranji SS, Al-jaf SM. Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish Population. Human Gene 2022;34:201115. [DOI: 10.1016/j.humgen.2022.201115] [Reference Citation Analysis]
2 Rupp SK, Weimer K, Goebel-stengel M, Enck P, Zipfel S, Stengel A. Genetics, shared environment, or individual experience? A cross-sectional study of the health status following SARS-CoV-2 infection in monozygotic and dizygotic twins. Front Psychiatry 2022;13. [DOI: 10.3389/fpsyt.2022.1048676] [Reference Citation Analysis]
3 Zhu F, Liu W, Liu T, Shi L, Zheng W, Guan F, Lei J. A New Role for Old Friends: Effects of Helminth Infections on Vaccine Efficacy. Pathogens 2022;11:1163. [PMID: 36297220 DOI: 10.3390/pathogens11101163] [Reference Citation Analysis]
4 Özbilen M, Bostan S, Kaya A, Kaya Y, Kurt C. The Effects of Demographic, Training, and Specialization Differences of Physicians in Coronavirus Disease 19 Treatment in Turkey. J Contin Educ Health Prof 2022;Publish Ahead of Print. [DOI: 10.1097/ceh.0000000000000464] [Reference Citation Analysis]
5 Elbadri SA, Abdallah NMA, El-shokry M, Gaber A, Elsayed MK. Association between single nucleotide polymorphism of human angiotensin-converting enzyme 2 gene locus and clinical severity of COVID-19. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00331-8] [Reference Citation Analysis]
6 Torrens-mas M, Perelló-reus CM, Trias-ferrer N, Ibargüen-gonzález L, Crespí C, Galmes-panades AM, Navas-enamorado C, Sanchez-polo A, Piérola-lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-freire M. GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility. Front Cell Infect Microbiol 2022;12:942951. [DOI: 10.3389/fcimb.2022.942951] [Reference Citation Analysis]
7 Tricarico G, Travagli V. Approach to the management of COVID-19 patients: When home care can represent the best practice. Int J Risk Saf Med 2022. [PMID: 35786662 DOI: 10.3233/JRS-210064] [Reference Citation Analysis]
8 Ishak A, Mehendale M, AlRawashdeh MM, Sestacovschi C, Sharath M, Pandav K, Marzban S. The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature. Gene 2022;836:146674. [PMID: 35714803 DOI: 10.1016/j.gene.2022.146674] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Russo A, Morrone HL, Rotundo S, Trecarichi EM, Torti C. Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets. Diagnostics 2022;12:1364. [DOI: 10.3390/diagnostics12061364] [Reference Citation Analysis]
10 Torrens-mas M, Perelló-reus CM, Trias-ferrer N, Ibargüen-gonzález L, Crespí C, Galmes-panades AM, Navas-enamorado C, Sanchez-polo A, Piérola-lopetegui J, Masmiquel L, Crespi LS, Barcelo C, Gonzalez-freire M. GDF15 and ACE2 stratify COVID19 patients according to severity while ACE2 mutations increase infection susceptibility.. [DOI: 10.1101/2022.05.06.490907] [Reference Citation Analysis]
11 Vadgama N, Kreymerman A, Campbell J, Shamardina O, Brugger C, Research Consortium GE, Deaconescu AM, Lee RT, Penkett CJ, Gifford CA, Mercola M, Nasir J, Karakikes I. SARS-CoV-2 Susceptibility and ACE2 Gene Variations Within Diverse Ethnic Backgrounds. Front Genet 2022;13:888025. [DOI: 10.3389/fgene.2022.888025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Texis T, Luis Cruz-jaramilllo J, García-muñoz W, Anzures-cortés L, Haddad-talancón L, Sánchez-garcía S, del Carmen Jiménez Martínez M, Pérez Barragán E, Nieto-patlán A, Martínez-ezquerro JD, Rubio-carrasco K, Rodríguez-dorantes M, Cortés-ramírez S, Mellado-sánchez G, Pérez-tapia SM, Gonzalez-covarrubias V. COVID-19 relevant genetic variants confirmed in an admixed population.. [DOI: 10.1101/2022.04.15.22273925] [Reference Citation Analysis]
13 Akelew Y, Andualem H, Ebrahim E, Atnaf A, Hailemichael W. Immunomodulation of COVID‐19 severity by helminth co‐infection: Implications for COVID‐19 vaccine efficacy. Immunity Inflam & Disease 2022;10. [DOI: 10.1002/iid3.573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Bahraini F, Karam F, Miri-moghaddam E. Genetic Factors Associated with Susceptibility and Mortality in COVID-19. Zahedan J Res Med Sci 2021;In Press. [DOI: 10.5812/zjrms.117622] [Reference Citation Analysis]
15 Gutiérrez-Valencia M, Leache L, Librero J, Jericó C, Enguita Germán M, García-Erce JA. ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis. Transfusion 2021. [PMID: 34773411 DOI: 10.1111/trf.16748] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
16 Jafarpour R, Pashangzadeh S, Dowran R. Host factors: Implications in immunopathogenesis of COVID-19. Pathol Res Pract 2021;228:153647. [PMID: 34749207 DOI: 10.1016/j.prp.2021.153647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pang X, Li P, Zhang L, Que L, Dong M, Xie B, Wang Q, Wei Y, Xie X, Li L, Yin C, Wei L, Huang K, Hua Y, Zhou Q, Li Y, Yu L, Li W, Mo Z, Zhang M, Leng J, Hu Y. Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Mutation Hotspots Associated With Clinical Outcomes and Transmission. Front Microbiol 2021;12:753823. [PMID: 34733263 DOI: 10.3389/fmicb.2021.753823] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
18 Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 2021;72:103629. [PMID: 34655949 DOI: 10.1016/j.ebiom.2021.103629] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 53.0] [Reference Citation Analysis]
19 Deng H, Yan X, Yuan L. Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 2021;6:344. [PMID: 34545062 DOI: 10.1038/s41392-021-00736-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
20 Vadgama N, Kreymerman A, Campbell J, Shamardina O, Brugger C, Lee RT, Penkett CJ, Gifford CA, Mercola M, Nasir J, Karakikes I, Genomics England Research Consortium. SARS-CoV-2 susceptibility and ACE2 gene variations within diverse ethnic backgrounds.. [DOI: 10.1101/2021.08.18.21261804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shindo Y, Kondoh Y, Kada A, Doi Y, Tomii K, Mukae H, Murata N, Imai R, Okamoto M, Yamano Y, Miyazaki Y, Shinoda M, Aso H, Izumi S, Ishii H, Ito R, Saito AM, Saito TI, Hasegawa Y. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure. Infect Dis Ther 2021. [PMID: 34368914 DOI: 10.1007/s40121-021-00512-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
23 Sayed S. COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario. Cancer Treat Res Commun 2021;28:100425. [PMID: 34171559 DOI: 10.1016/j.ctarc.2021.100425] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM, Sales LS, Barbosa ERO, Miranda ML, Salomão KB, Brighenti FL. COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. Eur J Clin Invest 2021;51:e13559. [PMID: 33772772 DOI: 10.1111/eci.13559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
25 Pang X, Li P, Zhang L, Que L, Dong M, Wang Q, Wei Y, Xie B, Xie X, Li L, Yin C, Wei L, Zhou Q, Li Y, Yu L, Li W, Mo Z, Leng J, Hu Y. Emerging SARS-CoV-2 mutation hotspots associated with clinical outcomes.. [DOI: 10.1101/2021.03.31.437666] [Reference Citation Analysis]